🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

201 results for “Ultragenyx UK Limited” Clear

  1. irradiation

    Ultragenyx UK Limited

    Brain Neoplasms

    phase 2 other active

    1 trial

  2. itraconazole

    Ultragenyx UK Limited

    Histoplasmosis

    phase 2 small molecule completed

    1 trial

  3. lactulose

    Ultragenyx UK Limited

    Portal Hypertension

    phase 2 small molecule completed

    1 trial

  4. leuprolide

    Ultragenyx UK Limited

    Spinal Muscular Atrophy

    phase 2 small molecule completed

    1 trial

  5. leuprolide

    Ultragenyx UK Limited

    Hyperandrogenism

    phase 2 small molecule completed

    1 trial

  6. leuprolide acetate

    Ultragenyx UK Limited

    Acanthosis Nigricans

    phase 2 small molecule completed

    1 trial

  7. lymphocyte gene therapy

    Ultragenyx UK Limited

    Mucopolysaccharidosis II

    phase 2 gene therapy completed

    1 trial

  8. methoxsalen

    Ultragenyx UK Limited

    Epidermolysis Bullosa Acquisita

    phase 2 small molecule completed

    1 trial

  9. monoclonal factor IX replacement therapy

    Ultragenyx UK Limited

    Hemophilia B

    phase 2 small molecule completed

    1 trial

  10. mucoid exopolysaccharide P. aeruginosa immune globulin IV

    Ultragenyx UK Limited

    Cystic Fibrosis

    phase 2 small molecule completed

    1 trial

  11. octreotide

    Ultragenyx UK Limited

    Hereditary Hemorrhagic Telangiectasia

    phase 2 small molecule completed

    1 trial

  12. olsalazine

    Ultragenyx UK Limited

    Ankylosing Spondylitis

    phase 2 small molecule completed

    1 trial

  13. pallidotomy

    Ultragenyx UK Limited

    Parkinson Disease

    phase 2 other completed

    1 trial

  14. pimozide

    Ultragenyx UK Limited

    Tourette Syndrome

    phase 2 small molecule completed

    1 trial

  15. relaxin

    Ultragenyx UK Limited

    Systemic Sclerosis

    phase 2 small molecule completed

    1 trial

  16. ribose

    Ultragenyx UK Limited

    5'-Nucleotidase Syndrome

    phase 2 small molecule completed

    1 trial

  17. risperidone

    Ultragenyx UK Limited

    Tourette Syndrome

    phase 2 small molecule completed

    1 trial

  18. rituximab

    Ultragenyx UK Limited

    Purpura, Thrombocytopenic, Idiopathic

    phase 2 small molecule completed

    1 trial

  19. scAAV8OTC

    Ultragenyx UK Limited

    Ornithine Transcarbamylase (OTC) Deficiency

    phase 2 gene therapy completed

    1 trial

  20. scAAV9/AGA

    Ultragenyx UK Limited

    Aspartylglucosaminuria

    phase 2 gene therapy active

    1 trial

  21. thalidomide

    Ultragenyx UK Limited

    HIV Infections

    phase 2 small molecule completed

    1 trial

  22. tin mesoporphyrin

    Ultragenyx UK Limited

    Hyperbilirubinemia

    phase 2 small molecule completed

    1 trial

  23. tin mesoporphyrin

    Ultragenyx UK Limited

    Glucosephosphate Dehydrogenase Deficiency

    phase 2 small molecule completed

    1 trial

  24. triheptanoin

    Ultragenyx UK Limited

    Rett Syndrome

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources